Golden State Equity Partners Mirum Pharmaceuticals, Inc. Transaction History
Golden State Equity Partners
- $182 Million
- Q3 2024
A detailed history of Golden State Equity Partners transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Golden State Equity Partners holds 1,300 shares of MIRM stock, worth $55,639. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,300
Previous 19,380
93.29%
Holding current value
$55,639
Previous $755,000
93.38%
% of portfolio
0.03%
Previous 0.17%
Shares
8 transactions
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$281 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$192 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$147 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$139 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$132 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.57B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...